Current management of infectious complications in the injecting drug user (Q41751175)

8 October 2017

1 reference

title

Current management of infectious complications in the injecting drug user (English)

1 reference

8 October 2017

Contoreggi C

1

1 reference

8 October 2017

Rexroad VE

series ordinal

2

1 reference

8 October 2017

Lange WR

series ordinal

3

1 reference

8 October 2017

publication date

1 March 1998

1 reference

Journal of Substance Abuse Treatment

8 October 2017

published in

1 reference

8 October 2017

volume

15

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

95-106

1 reference

Public policy statement on primary medical care for HIV infected patients in addiction treatment: American Society of Addiction Medicine

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Tricuspid valve endocarditis due to Staphylococcus aureus. Correlation of two-dimensional echocardiography with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Reverse genetic approaches to cloning deafness genes

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Immunologic dysfunction in heroin addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Cocaine use and the risk for endocarditis in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Infective endocarditis in drug addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Hyperimmunoglobulinemia associated with narcotic addiction. Effects of methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Biologic False-positive Reactions in Serologic Tests for Syphilis in Narcotic Addiction: Reduced Incidence during Methadone Maintenance Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

The practical business of treatment--13. Providing health care for drug users?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

The natural history of asymptomatic hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Treatment of resistant herpes simplex virus with continuous-infusion acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Blood-borne non-A, non-B hepatitis: hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-87.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Serologic markers of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Treatment of chronic type C hepatitis with alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

A controlled trial of zidovudine in primary human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Effects of retroviral infections on immune function in African-American intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Cryptococcosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Long-Term Methadone Maintenance Therapy: Effects on Liver Function

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Orthotopic liver transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Infective endocarditis in heroin addicts: epidemiological observations and some unusual cases

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Perspectives on linkage of primary health care and substance abuse treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Neuroradiologic findings in AIDS: a review of 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

AIDS commentary. Toxoplasmic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Binding of naloxone to human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Inability to predict diagnosis in febrile intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Racial differences in the use of drug therapy for HIV disease in an urban community

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Treatment of chronic hepatitis B with interferon: experience in western countries

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV- I, HBV, HCV) in Austrian intravenous drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Clindamycin for toxoplasma encephalitis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Pseudomonas endocarditis in the Detroit Medical Center. 1969-1972

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Hepatitis delta virus infection of the liver: progress in virology, pathobiology, and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Histoplasmosis in Patients at Risk for the Acquired Immunodeficiency Syndrome in a Nonendemic Setting

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Disseminated histoplasmosis in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Should patients with end-stage alcoholic liver disease have a new liver?

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Opioid peptides and opioid receptors in cells of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Increased rate of carriage of Staphylococcus aureus among narcotic addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Prevalence of HTLV-II in HIV-1-infected drug addicts in Marseille

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900048-2

7 January 2021

10.1016/S0740-5472(97)00048-2

Identifiers

DOI

1 reference

8 October 2017

1 reference